ArticleWorld journal of gastroenterology2025

NAD+/SIRT1 pathway regulates glycolysis to promote oxaliplatin resistance in colorectal cancer.

Ya-Ru Niu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.